Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul><li><keyword id="616857" type="ORGANIZATION" weightage="60" keywordseo="GW-Pharmaceuticals">GW Pharmaceuticals</keyword> stock soared 46% on Wednesday after Jazz Pharma said it would buy the company for $7.2 billion.</li><li>The proposed deal will include $200 in cash and $20 in shares of Jazz Pharma, and is expected to close in the second quarter of 2021.</li><li>GW Pharma is the first company to receive FDA approval for medicine derived from the cannabis plant.</li><li><a href="https://newsletter.businessinsider.com/join/4np/10-things-opening-bell?utm_source=markets&amp;utm_medium=ingestgest" target="_blank" rel="noopener">Sign up here for our daily newsletter, 10 Things Before the Opening Bell</a>.</li></ul><a href="https://markets.businessinsider.com/stocks/gwph-stock">GW Pharmaceuticals</a> soared as much as 46% on Wednesday after <a href="https://markets.businessinsider.com/stocks/jazz-stock">Jazz Pharma</a> said it <a href="https://ir.gwpharm.com/news-releases/news-release-details/jazz-pharmaceuticals-acquire-gw-pharmaceuticals-plc-creating">would acquire the company</a> for $7.2 billion in cash and stock.GW Pharma develops therapies derived from the marijuana plant. The UK-based company was the first to receive FDA approval for a cannabinoid-based therapy, Epidiolex, which is used to treat seizures in patients one-year and older.Epidiolex has hit approximately $510 million in annual sales within two years of its launch. Read More: <a href="https://www.businessinsider.com/stock-picks-to-buy-24-highest-conviction-buy-rated-stocks-2021-1?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingestm=ingest" target="_blank" rel="noopener noreferrer">Jefferies says to buy these 24 stocks that represent its analysts' highest-conviction picks for 2021</a>GW Pharma's pipeline is centered around cannabinoid-based medicines targeting epilepsies within neuroscience.The <keyword id="42411" type="PERSON" weightage="60" keywordseo="Merger">merger</keyword> is expected to accelerate double-digit top-line revenue growth and will be accretive in the first full year of combined operations, and "substantially accretive thereafter," the press release said. GW Pharma investors will receive $200 in cash and $20 in Jazz stock per share. The proposed deal price represents a 50% premium over GW's closing stock price on February 2 of $146.25.Jazz will fund the acquisition with a combination of cash and debt financing. "Given the strength of our balance sheet and the meaningful financial drivers of the transaction, we are confident in the value we can deliver to both companies' shareholders and patients," Jazz CEO Bruce Cozadd said. The board of directors of both companies have approved the proposed merger and the deal is expected to close in the second quarter of 2021.Shares of Jazz Pharma traded down 6% in Wednesday trades on the news.Read More: <a href="https://www.businessinsider.com/stocks-to-buy-silver-short-squeeze-stock-picks-rbc-2021-2?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingestm=ingest" target="_blank" rel="noopener noreferrer">Buy these 4 stocks poised benefit from a spike in silver prices, says RBC Capital Markets - including 2 set to soar 73%</a>

GW Pharmaceuticals soars 46% after Jazz Pharma agrees to $7.2 billion acquisition of the CBD biopharma company

<ul><li><keyword id="7404518" type="COMPANY" weightage="60" keywordseo="FLY-Leasing">Fly Leasing</keyword> jumped 26% on Monday after Carlyle Aviation Partners announced it would take the aircraft leasing firm private in a deal valued at $2.36 billion.</li><li>The deal is expected to close in the third quarter of this year.</li><li><a href="https://newsletter.businessinsider.com/join/4np/10-things-opening-bell">Sign up here for our daily newsletter, 10 Things Before the Opening Bell</a></li></ul>Fly Leasing jumped 26% on Monday after Carlyle Aviation Partners announced it is taking the aircraft leasing firm private for a total enterprise value of $2.36 billion, indicating a bullish stance on air travel as the economy shows signs of a rebound. Carlyle Aviation Partners in an <a href="https://www.prnewswire.com/news-releases/carlyle-aviation-to-acquire-fly-leasing-for-17-05-per-share-301257268.html">announcement</a> Monday said it will pay Fly Leasing shareholders $17.05 per share in cash, representing a total equity value of $520 million. Currently, the company's portfolio of 84 aircraft and seven engines, which are on lease to 37 airlines in 22 countries, will be added to the commercial aviation investment and servicing arm of The <keyword id="44803" type="CITY" weightage="60" keywordseo="Carlyle-group">Carlyle Group</keyword>. The deal is expected to close in the third quarter of this year.Due to the pending transaction, Fly said it will not host a first-quarter earnings call."This transaction represents strong value for Fly shareholders at a time when airlines are facing an extremely difficult environment and smaller aircraft lessors are disadvantaged in the debt <keyword id="31671" type="CITY" weightage="100" keywordseo="markets">markets</keyword>," said Colm Barrington, CEO of Fly.Airline companies were among the industries that suffered the most during the pandemic when large swaths of the global economy shut down, halting international and domestic travel. Leasing firms suffered more so during the pandemic. Still, optimism is growing in the industry, especially after the US Transportation Security Administration on March 15 revealed that air travel spiked to its <a href="https://markets.businessinsider.com/news/stocks/airline-stocks-united-southwest-american-delta-stock-price-air-travel-2021-3-1030205455#:~:text=to%20BI%20Prime-,Airline%20stocks%20rise%20as%20air%20travel%20climbs,level%20in%20nearly%20a%20year&amp;text=American%20Airlines%20and%20Southwest%20Airlines%20planes.&amp;text=Shares%20of%20airline%20companies%20rose,level%20in%20nearly%20a%20year.%20year.">highest level</a> in a year. Airlines are betting on consumers' pent-up desire to travel and move amid a steadying vaccine rollout. Two budget airlines in the US, Sun Country Airlines and Frontier Holding, have recently announced plans to go public amid an expected boom in travel this summer.

Fly Leasing spikes 26% as Carlyle Group plans to take company private in $2.36 billion deal

<ul><li><keyword id="11000430" type="UNKNOWN" weightage="60" keywordseo="bowx">BowX</keyword> jumped nearly 7% Friday on news it will take <keyword id="11000432" type="UNKNOWN" weightage="60" keywordseo="wework-public">WeWork public</keyword> via a SPAC merger. </li><li>The blank-check company will combine with <keyword id="2918346" type="PERSON" weightage="60" keywordseo="WeWork">WeWork</keyword> in a deal that values the co-working company at $9. </li><li>According to BowX's SEC filings, it initially set out to acquire a company in the technology, media, adn telecommunications space. </li><li><a href="https://newsletter.businessinsider.com/join/4np/10-things-opening-bell?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingestource=markets&amp;utm_medium=ingest?utm_source=markets&amp;utm_medium=ingest">Sign up here for our daily newsletter, 10 Things Before the Opening Bell</a>.</li></ul>The blank check company that is set to take WeWork public jumped as high as 6.77% in early trading on Friday. <a href="https://markets.businessinsider.com/stocks/bowx-stock">BowX Acquisition Corp </a>traded above $10.37 a share Friday after an announcement that <a href="https://www.businessinsider.com/wework-spac-bowx-merger-public-2021-3">it will combine with WeWork in a deal that values the co-working company at $9 billion</a>. <a href="https://www.wsj.com/articles/wework-agrees-to-spac-deal-that-would-take-https://www.wsj.com/articles/wework-agrees-to-spac-deal-that-would-take-startup-public-11616752804?mod=latest_headlines">The Wall Street Journal</a> first reported the merger Friday morning. <a href="https://www.wework.com/ideas/newsroom-landing-page/newsroom/posts/wework-to-become-publicly-traded-via-spac-merger-with-bowx-acquisition-corp">WeWork confirmed the deal in a press release</a>.The transaction will be funded with BowX's $483 million of cash in trust, WeWork said, in addition to an $800 million private investment group groups including Insight Partners, funds managed by Starwood Capital Group, Fidelity Management &amp; Research Company LLC, Centaurus Capital, and funds and accounts managed by BlackRock.The transaction is expected to close by the third quarter of 2021. BowX was formed by the management of venture capital fund Bow Capital. Vivek Ranadiv, who also owns the NBA's Sacramento Kings, and Murray Rode are the co-CEOs of the SPAC. According to BowX's SEC <a href="https://www.sec.gov/Archives/edgar/data/1813756/000121390020017847/fs12020_bowxacqu.htm">filings</a>, the blank check company initially set out to acquire a business in the technology, media, and telecommunications industries. The company said it aimed to invest in a technology company that capitalizes on trends in digital transformation, but added that there was potential it would target a business in any industry, sector, or geographic location of choice.

You Searched For "mergers adn acquisitions" and got 3 results

GW Pharmaceuticals soars 46% after Jazz Pharma agrees to $7.2 billion acquisition of the CBD biopharma company

Matthew Fox

Fly Leasing spikes 26% as Carlyle Group plans to take company private in $2.36 billion deal

Isabelle Lee

BowX jumps on reports it will take WeWork public via SPAC merger

Emily Graffeo

Popular Keywords

Buying Guides